Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2016

  1. Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma

    Oncotarget, Vol. 7, Núm. 51, pp. 85063-85078

2015

  1. TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling

    Molecular and Cellular Oncology, Vol. 2, Núm. 3

2013

  1. The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

    Oncogene, Vol. 32, Núm. 20, pp. 2534-2542

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9

  2. Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator Sei1

    PLoS ONE, Vol. 5, Núm. 1

2006

  1. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion

    Journal of Immunology, Vol. 176, Núm. 1, pp. 589-593

  2. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62

    Cell Metabolism, Vol. 3, Núm. 3, pp. 211-222

  3. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma

    Oncogene, Vol. 25, Núm. 29, pp. 4128-4132

2005

  1. Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms

    Journal of Clinical Investigation, Vol. 115, Núm. 9, pp. 2351-2362

  2. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus

    Nature Medicine, Vol. 11, Núm. 9, pp. 933-935

2004

  1. Crosstalk between PKCζ and the IL4/Stat6 pathway during T-cell-mediated hepatitis

    EMBO Journal, Vol. 23, Núm. 23, pp. 4595-4605

  2. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice

    European Journal of Immunology, Vol. 34, Núm. 2, pp. 548-557

  3. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis

    Developmental Cell, Vol. 6, Núm. 2, pp. 303-309

2003

  1. CCR6 has a non-redundant role in the development of inflammatory bowel disease

    European Journal of Immunology, Vol. 33, Núm. 10, pp. 2937-2946

2000

  1. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo

    FASEB Journal, Vol. 14, Núm. 7, pp. 895-903